Skip to main content
NIH funding notice RFA-AI-23-020

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)

Closed on June 8, 2023.

Posted
March 16, 2023
Close date
June 8, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $216,707,392 in first-year total cost, median $39,565,623.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 FDS-M (J1)]6

Most frequent institutions

  1. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  2. UNIVERSITY OF CALIFORNIA-IRVINE1
  3. UNIVERSITY OF TEXAS MED BR GALVESTON1
  4. UNIVERSITY OF WASHINGTON1
  5. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under RFA-AI-23-020 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)1U19AI181930-01BRODER, CHRISTOPHER CGEISBERT, THOMAS WILLIAMUNIVERSITY OF TEXAS MED BR GALVESTON, TX$46,404,982ZAI1
2024Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP1U19AI181984-01MOSCONA, ANNERAPPUOLI, RINOWHELAN, SEAN PJWASHINGTON UNIVERSITY, MO$44,108,652ZAI1
2024Machine learning-enabled design of prototype pathogen vaccines and antibodies1U19AI181881-01KING, NEILSTUART, LYNDAVEESLER, DAVIDUNIVERSITY OF WASHINGTON, WA$41,075,241ZAI1
2024Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center1U19AI181979-01CROWE, JAMES EVANDERBILT UNIVERSITY MEDICAL CENTER, TN$38,056,004ZAI1
2024The UCI Vaccines for Pandemic Preparedness Center (VPPC)1U19AI181968-01FELGNER, PHILIP LOUISUNIVERSITY OF CALIFORNIA-IRVINE, CA$33,116,067ZAI1
2024PROVIDENT: Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics against Diverse Emerging Infectious Threats1U19AI181977-01CHANDRAN, KARTIKALBERT EINSTEIN COLLEGE OF MEDICINE, NY$13,946,446ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-23-020: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed) | ScienceDex | ConductScience